X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs BIOCON LTD - Comparison Results

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES BIOCON LTD JUBILANT LIFE SCIENCES/
BIOCON LTD
 
P/E (TTM) x 20.8 37.7 55.2% View Chart
P/BV x 4.4 5.0 88.3% View Chart
Dividend Yield % 0.4 1.5 27.9%  

Financials

 JUBILANT LIFE SCIENCES   BIOCON LTD
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
BIOCON LTD
Mar-16
JUBILANT LIFE SCIENCES/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs187496 37.7%   
Low Rs65397 16.4%   
Sales per share (Unadj.) Rs364.3174.3 209.1%  
Earnings per share (Unadj.) Rs6.844.8 15.3%  
Cash flow per share (Unadj.) Rs24.556.9 43.0%  
Dividends per share (Unadj.) Rs3.005.00 60.0%  
Dividend yield (eoy) %2.41.1 212.5%  
Book value per share (Unadj.) Rs164.9202.8 81.3%  
Shares outstanding (eoy) m159.28200.00 79.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.32.6 13.5%   
Avg P/E ratio x18.410.0 184.8%  
P/CF ratio (eoy) x5.17.8 65.6%  
Price / Book Value ratio x0.82.2 34.7%  
Dividend payout %43.811.2 392.7%   
Avg Mkt Cap Rs m20,06189,220 22.5%   
No. of employees `0006.24.4 140.1%   
Total wages/salary Rs m11,0526,363 173.7%   
Avg. sales/employee Rs Th9,383.07,894.5 118.9%   
Avg. wages/employee Rs Th1,786.91,441.2 124.0%   
Avg. net profit/employee Rs Th176.32,029.7 8.7%   
INCOME DATA
Net Sales Rs m58,03434,854 166.5%  
Other income Rs m191845 22.6%   
Total revenues Rs m58,22435,699 163.1%   
Gross profit Rs m5,7868,200 70.6%  
Depreciation Rs m2,8122,423 116.0%   
Interest Rs m3,237102 3,173.7%   
Profit before tax Rs m-726,520 -1.1%   
Minority Interest Rs m-286-744 38.4%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1455,754 37.3%   
Tax Rs m6962,569 27.1%   
Profit after tax Rs m1,0908,961 12.2%  
Gross profit margin %10.023.5 42.4%  
Effective tax rate %-965.939.4 -2,451.4%   
Net profit margin %1.925.7 7.3%  
BALANCE SHEET DATA
Current assets Rs m29,28039,932 73.3%   
Current liabilities Rs m38,91216,276 239.1%   
Net working cap to sales %-16.667.9 -24.5%  
Current ratio x0.82.5 30.7%  
Inventory Days Days8454 157.5%  
Debtors Days Days5186 58.8%  
Net fixed assets Rs m55,71239,101 142.5%   
Share capital Rs m1551,000 15.5%   
"Free" reserves Rs m20,96838,591 54.3%   
Net worth Rs m26,26540,556 64.8%   
Long term debt Rs m17,16920,724 82.8%   
Total assets Rs m88,60684,816 104.5%  
Interest coverage x1.064.9 1.5%   
Debt to equity ratio x0.70.5 127.9%  
Sales to assets ratio x0.70.4 159.4%   
Return on assets %4.910.7 45.7%  
Return on equity %4.222.1 18.8%  
Return on capital %11.619.0 60.9%  
Exports to sales %37.830.7 122.9%   
Imports to sales %16.520.4 80.9%   
Exports (fob) Rs m21,93310,717 204.7%   
Imports (cif) Rs m9,5677,105 134.7%   
Fx inflow Rs m22,00411,789 186.6%   
Fx outflow Rs m11,7498,393 140.0%   
Net fx Rs m10,2553,396 302.0%   
CASH FLOW
From Operations Rs m8,0265,264 152.5%  
From Investments Rs m-1,744-9,540 18.3%  
From Financial Activity Rs m-4,44710,867 -40.9%  
Net Cashflow Rs m1,8346,591 27.8%  

Share Holding

Indian Promoters % 45.6 40.4 112.9%  
Foreign collaborators % 3.5 20.6 17.0%  
Indian inst/Mut Fund % 8.7 8.4 103.6%  
FIIs % 21.2 10.7 198.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 19.9 106.0%  
Shareholders   23,815 109,995 21.7%  
Pledged promoter(s) holding % 15.9 0.0 39,625.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   ASTRAZENECA PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  GSK PHARMA  PLETHICO PHARMA  

Compare JUBILANT LIFE SCIENCES With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; Pharma Sector Up 2.4%(11:30 am)

Stock markets in India are presently trading near the dotted line with positive bias. Sectoral indices are trading on a mixed note with stocks in the healthcare sector.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Biocon: A Good Quarter (Quarterly Results Update - Detailed)

May 10, 2016

Biocon has announced its 4QFY16 and full year results. The company has reported 16.8% YoY growth in total income and 79.1% YoY increase in net profits. Here is our analysis of the results.

Biocon: Exceptional income saves the day (Quarterly Results Update - Detailed)

Jan 28, 2016

Biocon has announced its 2QFY16 results. The company has reported 10.5% YoY growth in total income and 199.9% YoY increase in net profits. Here is our analysis of the results.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Aug 24, 2017 12:24 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS